Shots:
Senseonics has filed for the CE Mark Approval of its Eversense 365 CGM system. If approved, it will be distributed in the EU (Germany, Italy, Spain, Poland, Switzerland, Sweden, & Andorra) by Ascensia Diabetes Care (Senseonics' commercial partner)
Eversense offers longevity (1yr. vs 10-14 days for traditional CGMs), features a removable smart transmitter…
